Skip to content
The Nexus
DossierENTITY

therapy target

Coverage of therapy target in the Nexus archive.

Earliest in view: Apr 20 · 11:14 UTCMost recent: Apr 20 · 11:14 UTC
Co-mentioned in this coverage
vitamin B7topic1biotintopic1cancer cellstopic1glutamine addictiontopic1metabolic 'license'topic1key enzymetopic1cancer-linked genetopic1
Recent coverage
  • HEALTHApr 20 · 11:14 UTCSCIENCE DAILY
    This missing vitamin could stop cancer cells in their tracks

    Cancer cells rely on glutamine but can switch fuels using vitamin B7 (biotin), which acts as a metabolic 'license' via a key enzyme. Without biotin, cancer cells lose this metabolic flexibility and stop growing. Mutations in a cancer-linked gene amplify this vulnerability, offering a potential new therapeutic target.